Larimar Therapeutics, Inc. logo LRMR - Larimar Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $12.00 DETAILS
HIGH: $12.00
LOW: $12.00
MEDIAN: $12.00
CONSENSUS: $12.00
UPSIDE: 247.83%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 0.2 0.1 0.3 0.2 0.2 0.1 0 0.0 0.0 0.0
Gross Profit 0 0 0 0 0 (0.2) (0.1) (0.3) (0.2) (0.2) (0.1) 0 (0.0) (0.0) (0.0)
Operating Expenses
R&D Expenses 154.2 73.3 27.7 24.2 38.4 31.3 20.8 49.5 41.7 39.8 54.6 27.4 9.6 11.5 11.4
SG&A Expenses 18.3 17.6 14.1 12.3 12.1 11.4 2.4 12.9 11.9 17.1 19.1 8.1 4.2 2.2 1.7
Other Expenses 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0
Operating Expenses 172.5 90.9 41.8 36.5 50.5 42.6 23.2 62.5 53.7 56.9 73.7 35.5 13.8 13.8 13.2
Operating Income
Operating Income (172.5) (90.9) (41.8) (36.5) (50.5) (42.8) (23.2) (62.7) (53.9) (57.1) (73.8) (35.5) (13.8) (13.8) (13.2)
Interest Expense 0 0 0 0 0 0 0 0 1.0 0.3 0.8 (0.9) 0 0.1 0
Interest Income 0 0 0 0 0 0 0 0 1.0 0.9 0.4 0.0 0 0 0
Profitability
EBITDA (172.1) (90.6) (41.4) (36.2) (50.1) (42.6) (23.1) (60.8) (52.6) (57.4) (73.4) (35.5) (14.0) (13.8) (13.2)
EBIT (172.5) (90.9) (41.8) (36.5) (50.5) (42.8) (23.2) (61.1) (52.8) (57.6) (73.5) (35.6) (14.0) (13.8) (13.2)
Income Before Tax (165.7) (80.6) (36.9) (35.4) (50.6) (42.5) (23.1) (63.0) (52.9) (58.2) (74.3) (36.6) (14.0) (13.9) (13.2)
Income Tax Expense 0 0 0 0 0 0 0 (1.6) (0.9) (0.3) 0 0 0 0 0
Net Income (165.7) (80.6) (36.9) (35.4) (50.6) (42.3) (23.1) (61.4) (52.0) (57.9) (74.3) (36.6) (14.0) (13.9) (13.2)
Per Share Data
EPS (Basic) -2.27 -1.32 -0.84 -1.33 -2.93 -3.56 -2.51 -22.85 -22.76 -25.44 -33.32 -15.14 -6.54 -6.40 -6.07
EPS (Diluted) -2.27 -1.32 -0.84 -1.33 -2.93 -3.56 -2.51 -22.85 -22.76 -25.44 -33.32 -15.14 -6.54 -6.40 -6.07
Shares Outstanding 72.9 61.3 43.9 25.8 17.2 11.9 9.2 2.7 2.3 2.3 2.2 2.4 2.2 2.2 2.2
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 85.4 33.2 26.7 26.8 70.1 68.1 1.0 49.3 40.8 32.4
Short-Term Investments 51.4 150.2 60.0 91.6 0 24.5 0 68.7 61.3 96.8
Net Receivables 0.7 1.1 0 0 0.2 0.0 0.2 1.5 0.9 0.3
Inventory 0 0 0 0 0 0 0 0 0 0
Other Current Assets 4.4 10.8 0.7 0.2 0.3 0.3 0.4 1.7 1.9 1.4
Total Current Assets 142.0 195.3 90.2 120.7 72.2 98.0 4.8 121.3 104.9 130.9
Non-Current Assets
Property, Plant & Equipment 2.7 3.7 3.8 3.7 4.5 5.0 0.4 0.4 0.5 0.7
Goodwill 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 1.3 0 0 0 0 0 0 0
Other Non-Current Assets 1.1 1.2 0.7 2.0 2.0 1.8 0.1 0.1 0.1 0.1
Total Non-Current Assets 3.8 4.9 5.8 5.7 6.5 6.7 0.5 0.4 0.6 0.7
Total Assets 145.8 200.2 95.9 126.4 78.7 104.7 5.2 121.8 105.5 131.6
Current Liabilities
Account Payables 5.2 2.4 1.3 1.7 1.7 2.6 3.5 0.9 0 0
Short-Term Debt 1.1 0 0 0 0 0 0 5.5 0 3.6
Deferred Revenue 0 0 0 0 0 0 0 (5.5) 0 (2.6)
Other Current Liabilities 58.5 0 0 0 0 0 0 4.7 4.3 6.3
Total Current Liabilities 64.8 24.4 9.5 10.7 8.8 9.0 5.9 13.3 7.3 9.9
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 15.2 20 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Total Non-Current Liabilities 3.0 4.1 4.7 4.8 5.4 6.0 0 15.2 20 0
Total Liabilities 67.8 28.4 14.2 15.5 14.3 15.0 5.9 28.5 27.3 9.9
Stockholders' Equity
Common Stock 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (434.8) (269.2) (188.6) (151.6) (116.2) (65.6) (23.1) (350.9) (289.6) (237.5)
Accumulated Other Comprehensive Income 0.1 0.1 0.1 (0.0) 0 0.0 0 (0.0) (0.1) (0.1)
Total Stockholders' Equity 78.1 171.8 81.7 110.9 64.4 89.7 (0.7) 93.3 78.2 121.7
Total Liabilities & Equity 145.8 200.2 95.9 126.4 78.7 104.7 5.2 121.8 105.5 131.6
Debt Metrics
Total Debt 4.1 5.1 5.5 5.4 6.0 6.5 0.1 20.6 20 3.6
Net Debt (81.3) (28.1) (21.2) (21.4) (64.1) (61.6) (0.9) (28.7) (20.8) (28.8)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (165.7) (80.6) (36.9) (35.4) (50.6) (42.5) (23.1) (61.4) (52.0) (57.9)
Depreciation & Amortization (1.3) 0.3 0.3 0.3 0.3 0.2 0.1 0.3 0.2 0.2
Stock-Based Compensation 7.0 8.8 0 6.6 5.5 2.2 0.1 0.2 0 0
Change in Working Capital 47.1 6.2 (2.5) 1.7 2.7 (2.0) 0.2 0.6 (0.1) (5.5)
Other Non-Cash Items (0.3) (5.4) 5.7 (0.8) (0.0) 0.0 0 9.8 9.1 10.6
Operating Cash Flow (113.2) (70.8) (33.5) (27.6) (42.1) (42.2) (22.7) (51.5) (43.8) (52.0)
Investing Activities
Capital Expenditure (0.1) (0.5) (0.2) (0.1) (0.3) (0.1) (0.1) (0.1) (0.1) (0.7)
Acquisitions 0 0 0 0.1 (0.0) (1.3) 0 6.8 0 0
Purchases of Investments (83.6) (227.9) (101.2) (133.6) (8.2) (24.5) 0 (117.1) (114.5) (136.5)
Sales/Maturities of Investments 184 143 134.8 42.8 32.8 1 0 110.4 150.2 188.6
Other Investing Activities 0 0 0 (0.1) 0.0 41.9 0 (6.8) 35.7 0.0
Investing Cash Flow 100.3 (85.4) 33.4 (91.0) 24.2 17.1 (0.1) (6.9) 35.6 51.4
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 16.4 (2.9)
Stock Repurchased 0 0 0 0 0 0 0 67.2 0.2 0.2
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0.1 0 0 0 18.0 0 0 0 0
Financing Cash Flow 65.1 161.9 0.0 75.3 19.9 93.6 19.4 66.9 16.6 (2.7)
Cash Position
Net Change in Cash 52.2 5.7 (0.1) (43.3) 1.9 68.5 (48.3) 8.6 8.4 (3.2)
Cash at Beginning 33.8 28.1 26.8 71.4 69.5 1.0 49.3 40.8 32.4 35.6
Cash at End 86.0 33.8 26.7 28.2 71.4 69.5 1.0 49.3 40.8 32.4
Free Cash Flow (113.3) (71.3) (33.6) (27.7) (42.4) (42.3) (22.8) (51.6) (43.8) (52.6)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 (0.2) (0.1) (0.3) (0.2) (0.2) (0.1) 0 (0.0) (0.0) (0.0)
Operating Income (172.5) (90.9) (41.8) (36.5) (50.5) (42.8) (23.2) (62.7) (53.9) (57.1) (73.8) (35.5) (13.8) (13.8) (13.2)
Net Income (165.7) (80.6) (36.9) (35.4) (50.6) (42.3) (23.1) (61.4) (52.0) (57.9) (74.3) (36.6) (14.0) (13.9) (13.2)
EPS (Diluted) -2.27 -1.32 -0.84 -1.33 -2.93 -3.56 -2.51 -22.85 -22.76 -25.44 -33.32 -15.14 -6.54 -6.40 -6.07
Balance Sheet
Cash & Equivalents 85.4 33.2 26.7 26.8 70.1 68.1 1.0 49.3 40.8 32.4
Total Assets 145.8 200.2 95.9 126.4 78.7 104.7 5.2 121.8 105.5 131.6
Total Debt 4.1 5.1 5.5 5.4 6.0 6.5 0.1 20.6 20 3.6
Stockholders' Equity 78.1 171.8 81.7 110.9 64.4 89.7 (0.7) 93.3 78.2 121.7
Cash Flow
Operating Cash Flow (113.2) (70.8) (33.5) (27.6) (42.1) (42.2) (22.7) (51.5) (43.8) (52.0)
Capital Expenditure (0.1) (0.5) (0.2) (0.1) (0.3) (0.1) (0.1) (0.1) (0.1) (0.7)
Free Cash Flow (113.3) (71.3) (33.6) (27.7) (42.4) (42.3) (22.8) (51.6) (43.8) (52.6)